NCT05457023 is a clinical trial of Plasma Neurofilament Light (NF-L) in Brain Trauma, sponsored by University of Kansas Medical Center.

Who is sponsoring NCT05457023?

NCT05457023 is sponsored by University of Kansas Medical Center.

What drugs are being tested in NCT05457023?

Interventions in NCT05457023: Plasma Neurofilament Light (NF-L), Omega-3 Index, HeadCount Questionnaire.

What condition does NCT05457023 study?

NCT05457023 studies Brain Trauma.

Is NCT05457023 still recruiting?

NCT05457023 is currently completed. Last updated 13 November 2023.

Last reviewed 2023-11-13 · How we verify

NCT05457023

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Plasma Neurofilament Light and Its Relationship With Omega-3 Status and Soccer Heading in Women Soccer Players

Completed Last updated 13 November 2023

What this trial tests

trial testing Plasma Neurofilament Light (NF-L) in Brain Trauma in 27 participants. Completed in 9 November 2023.

Timeline

28 July 2022

Primary endpoint
9 November 2023

9 November 2023

Quick facts

Lead sponsor	University of Kansas Medical Center
Status	Completed
Study type	OBSERVATIONAL
Enrollment	27
Start date	28 July 2022
Primary completion	9 November 2023
Estimated completion	9 November 2023
Sites	2 locations across United States

Drugs / interventions tested

Plasma Neurofilament Light (NF-L)
Omega-3 Index
HeadCount Questionnaire

Conditions studied

Brain Trauma — all drugs for Brain Trauma →

Sponsor

University of Kansas Medical Center

Who can join

Adults 18 to 25, female only, with Brain Trauma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to (1) assess how a competitive season of purposeful gameplay soccer heading in collegiate women soccer players is related to a blood biomarker for sports-related brain injury, plasma neurofilament light (NF-L), and (2) examine how a player's omega-3 status is related to plasma NF-L concentration changes during and after a competitive season of gameplay soccer heading.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Brain Trauma

Currently open trials in the same condition.

NCT06413173 — Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric) · NA · recruiting

Other University of Kansas Medical Center trials

Trials by the same sponsor.

NCT06636214 — Adapting Changing Talk: Online (CHATO) to CHATO-Inclusive · NA · not yet recruiting
NCT07528963 — KanSurvive 2.0: Testing Enhanced Models of Cancer Survivorship Care for Rural Cancer Survivors in Primary Care Practice · NA · enrolling by invitation
NCT07463755 — Low-Fidelity Driving Simulator Training in Parkinson's Disease. · NA · not yet recruiting
NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07491510 — Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05457023 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Kansas Medical Center
Last refreshed: 13 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05457023.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing